Oxford/AstraZeneca (AZN) vaccine data looks 'mediocre' - STAT's Feuerstein

Oxford/AstraZeneca (NYSE: AZN) vaccine data looks "mediocre", STAT's Adam Feuerstein said on Twitter.

I am NOT a vaccine expert but the Oxford $AZN data look mediocre to me — disappointing relative to all the hype coming into Monday.

Is this how others more knowledgable than me see it, too?

What am I missing here?

— Adam Feuerstein (@adamfeuerstein) July 20, 2020

You May Also Be Interested In

• TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
• NeOnc reports Phase 2a brain cancer trial results, plans FDA meeting
• FDA: issues early alert on Abiomed heart pump controller purge cassette issue